Taltirelin (Tanabe Seiyaku).
作者： W M Brown
DOI:
关键词:
摘要: Taltirelin (TA-0910), a synthetic thyrotropin-releasing hormone (TRH) analog, has been developed by Tanabe Seiyaku for the treatment of neurodegenerative diseases [154099], [263997]. An NDA was filed in Japan April 1999 spinocerebellar degeneration (SCD) [296442] and approved July 2000 [391719]; drug launched September [382555], [383484]. It is first orally administered this indication [382555]. In 2001, UBS Warburg (Japan) stated that total sales taltirelin were Yen 3.5 bn, estimated 2001 would reach 7.6 rising to 8.6 bn 2005 [433991]. Also month, Morgan Stanley predicted there be 8 10 2002 [422782].
参考文章(76)
Yasuo Fukuuchi, Satoru Komatsumoto, Naoki Ishihara, Akira Imai, Yoshio Izumi, Effect of Thyrotropin-Releasing Hormone (TRH) on Cerebral Blood Flow in Spinocerebellar Degeneration and Cerebrovascular Disease The Tokai journal of experimental and clinical medicine. ,vol. 20, pp. 203- 208 ,(1995)
I Kanazawa, Clinical evaluation of taltirelin hydrate (TA-0910) in patients with spinocerebellar degeneration: A multi-center double-blind comparative study with placebo Journal of Clinical Therapeutics & Medicines. ,vol. 13, pp. 4169- 4224 ,(1997)
K A Sevarino, R H Goodman, J Spiess, I M Jackson, P Wu, Thyrotropin-releasing hormone (TRH) precursor processing. Characterization of mature TRH and non-TRH peptides synthesized by transfected mammalian cells. Journal of Biological Chemistry. ,vol. 264, pp. 21529- 21535 ,(1989) , 10.1016/S0021-9258(20)88217-9
S Manaker, A Winokur, WH Rostene, TC Rainbow, Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system The Journal of Neuroscience. ,vol. 5, pp. 167- 174 ,(1985) , 10.1523/JNEUROSCI.05-01-00167.1985
Y Takaya, K Ogawara, M Waragai, M Hayashi, [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy]. Rinshō shinkeigaku Clinical neurology. ,vol. 37, pp. 587- 594 ,(1997)
T. Monden, H. Mizuma, M. Yamada, M. Murakami, M. Mori, A NOVEL ANALOG OF TRH, YM14673, CAUSES A DECREASE IN BRAIN TRH RECEPTORS IN VITRO Endocrine Research. ,vol. 21, pp. 803- 814 ,(1995) , 10.1080/07435809509030493
Kiyoshi KINOSHITA, Michio YAMAMURA, Juko SUGIHARA, Distribution of Thyrotropin-Releasing Hormone (TRH) Receptors in the Brain of the Ataxic Mutant Mouse, Rolling Mouse Nagoya Biological & Pharmaceutical Bulletin. ,vol. 20, pp. 86- 87 ,(1997) , 10.1248/BPB.20.86
George G. Yarbrough, Nuhzio Pomara, The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD) Progress in Neuro-Psychopharmacology and Biological Psychiatry. ,vol. 9, pp. 285- 289 ,(1985) , 10.1016/0278-5846(85)90092-2
Takaaki YAMAMURA, Tomonari NISHIMURA, Yuki KUWAMURA, Toshihide INUI, Pete AUGHTON, Yoshiaki KAWAI, ONCOGENICITY STUDIES OF TALTIRELIN TETRAHYDRATE (TA-0910) BY ORAL (GAVAGE) ADMINISTRATION IN CD-1 MICE AND CD RATS Journal of Toxicological Sciences. ,vol. 22, pp. 419- 430 ,(1997) , 10.2131/JTS.22.SUPPLEMENTII_419
Michio Yamamura, Kiyoshi Kinoshita, Hiroyuki Nakagawa, Ryuichi Ishida, Pharmacological Study of TA-0910, a New Thyrotropin-Releasing Hormone (TRH) Analog (IV): Effects on Experimental Memory Impairment in Mice and Rats Japanese Journal of Pharmacology. ,vol. 55, pp. 241- 253 ,(1991) , 10.1254/JJP.55.241